Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Birmingham, AL Law Firm Barclay Law LLC, Comments on Report about Blood-Thinning Drug Xarelto
  • USA - English


News provided by

Big Voodoo Interactive

Aug 28, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Birmingham, AL (PRWEB) August 28, 2014 -- Blood-thinning prescription medication Xarelto has been linked to adverse side effects, according to several recent news articles, a serious issue that raises concerns among people who take this powerful drug, according to Birmingham, Alabama dangerous drug attorney John Michael Barclay of Barclay Law LLC, who urges people injured by Xarelto to discuss their legal options with an experienced lawyer.

Although powerful drugs like Xarelto are required to go through rigorous testing before being released to the market, sometimes these drugs do more harm than good.

Post this

Barclay based his comments on several articles and studies detailing the drug’s potentially harmful side effects, including an article published by DrugWatch.(“First Xarelto Bleeding Lawsuits Filed; FDA Rejects New Use,” Aug. 4, 2014)

“Barclay Law is currently considering cases on behalf of those injured, or whose loved ones died, allegedly as a result of taking Xarelto,” Barclay said today. “Although powerful drugs like Xarelto are required to go through rigorous testing before being released to the market, sometimes these drugs do more harm than good.”

According to DrugWatch, numerous lawsuits have been filed against Bayer AG, which manufactures Xarelto, and its United States distributor, Johnson & Johnson, after multiple patients experienced severe internal bleeding. Unlike similar blood-thinning medications within the same drug class (anticoagulants), Xarelto does not have an antidote to stop uncontrolled and potentially fatal internal bleeding, according to DrugWatch.

Due to the risks associated with Xarelto, the U.S. Food and Drug Administration (FDA) changed its boxed label warning on Xarelto in March 2014. According to the FDA, potential Xarelto side effects include uncontrollable bleeding. Furthermore, the FDA reports that no antidote currently exists to reverse potentially serious side effects associated with the drug.

The Institute of Safe Medication Practices (“Quarter Watch: Monitoring FDA MedWatch Reports: Perspective on Drug Hyper Sensitivity: Executive Summary,” May 7, 2014) reported that during the first quarter of 2013, adverse event reports involving Xarelto (680) surpassed that of Pradaxa (528), which ranked as the number one anticoagulant drug for adverse events in 2012.

Such risks must be taken seriously by consumers and further investigated by researchers, according to Barclay, lead attorney at Birmingham law firm Barclay Law, LLC.

“Drug manufacturers have a moral and legal obligation to adequately test products for safety before releasing them to the market,” Barclay said. “We understand this is not always the case. We also understand that it can be difficult knowing what to do after suffering adverse effects from a dangerous drug. You might think drug manufacturers will cover the true cost of your injuries, including medical bills and lost wages from missing work. Unfortunately, that’s not always the case. You might be entitled to more compensation than drug manufacturers and their insurance companies want to pay you. If you’ve been injured or a loved one died, you have rights. We strongly urge you to contact us immediately and discuss your legal options.”

About Barclay Law LLC

Serving clients throughout Alabama, attorney John Michael Barclay spent the first years of his practice representing injured people. He continues to fight for the injured and families who have lost loved ones. In addition, he handles criminal defense cases. As the founding member of Barclay Law LLC, he assists clients facing a variety of difficult legal challenges, including personal injury claims, white collar defense, DUI charges, drug offenses and other serious legal matters. Attorney Barclay believes that anyone injured or who loses a loved one through no fault of their own deserves a fearless and dedicated lawyer. He is a skilled negotiator who is beholden to his profession and is guided by the belief that he has the ability to zealously represent his clients.

Mr. Barclay has been consistently named one of Birmingham Magazine's Top Attorneys in the area of Criminal Defense. He also has been included in the prestigious list of Alabama Super Lawyers™ Rising Stars for 2012 and 2013. Selection is made by lawyers chosen for the highly respected Super Lawyers Honor who are asked to nominate the best attorneys they have worked with under the age of 40 or who have been practicing for 10 years or less. No more than 2.5 percent of the lawyers in any state can be named a Rising Star. Attorney Barclay also has one of the highest Martindale-Hubbell Peer Review AV Ratings for attorneys in Alabama, receiving an AV® Preeminent™ score of 4.7 out of 5 in Criminal Law, Litigation and Family Law. Mr. Barclay is also a member of the Alabama Criminal Defense Lawyers Association.

Barclay Law LLC is located at 2100 Morris Ave, Birmingham, AL 35203. Call 866-584-1023 or 205-488-2797 for a free consultation. Visit http://www.jmbarclaylaw.com.

Jacob M Del Hagen, Big Voodoo Interactive, http://www.bigvoodoo.com, +1 (413) 650-0593, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.